ACRS
Aclaris Therapeutics, Inc. · Healthcare
Director Andrew N Schiff sold $862K of Aclaris Therapeutics, Inc.
Sold$862,109
$16.57Price
52,037Shares
−9%Stake
What ACRS did after the filing
- The stock from Wed, Oct 19 close, $16.12
- −1.6%
- S&P 500, same days
- +10.6%
Measured over 30 trading days, to the Dec 1 close.
Traded Mon, Oct 17. Filed Wed, Oct 19, 12:49 PM ET, during the session. Returns use the Oct 19 close and the Dec 1 close. Not investment advice.